Showing results (101-110 of 111) with videos related to
Sort By:
Pageof 12
Movement Disorders : Official Journal of the Movement Disorder Society|June 14, 2022
Adult-Onset Neurodegeneration in Nucleotide Excision Repair Disorders (NERD<sub>ND</sub> ): Time to Move Beyond the SkinIsabell Cordts, Demet Önder, Andreas Traschütz, et al.NPJ Parkinson'S Disease|August 15, 2024
Risk willingness in multiple system atrophy and Parkinson's disease understanding patient preferencesAlexander Maximilian Bernhardt, Marc Oeller, Isabel Friedrich, et al.The Lancet. Neurology|March 22, 2020
Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort studyTim Hagenacker, Claudia D Wurster, René Günther, et al.Oncotarget|November 24, 2016
Prognostic relevance of miRNA-155 methylation in anaplastic gliomaMaximilian Georg Schliesser, Rainer Claus, Thomas Hielscher, et al.JAMA|September 28, 2023
Eplontersen for Hereditary Transthyretin Amyloidosis With PolyneuropathyTeresa Coelho, Wilson Marques, Noel R Dasgupta, et al.Journal of Neuromuscular Diseases|September 12, 2025
Phenotypic intrafamilial variability of 5q-associated spinal muscular atrophy: A systematic multicentre sibling studyBenedikt Becker, Isabell Cordts, Jutta Becker, et al.Neurological Research and Practice|July 3, 2024
Patients' and caregivers' perception of multidimensional and palliative care in amyotrophic lateral sclerosis - protocol of a German multicentre studyKatharina Linse, Constanze Weber, Peter Reilich, et al.Journal of Neuromuscular Diseases|December 24, 2022
Improvements in Walking Distance during Nusinersen Treatment - A Prospective 3-year SMArtCARE Registry StudyAstrid Pechmann, Max Behrens, Katharina Dörnbrack, et al.Orphanet Journal of Rare Diseases|October 24, 2022
Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry studyAstrid Pechmann, Max Behrens, Katharina Dörnbrack, et al.Journal of Neurology|February 27, 2024
5qSMA: standardised retrospective natural history assessment in 268 patients with four copies of SMN2Katharina Vill, Moritz Tacke, Anna König, et al.Pageof 12